GELS
Gelteq Ltd
NASDAQ · Pharmaceuticals
$0.81
+0.01 (+0.76%)
Open$0.79
Previous Close$0.80
Day High$0.88
Day Low$0.79
52W High$28.51
52W Low$16.56
Volume—
Avg Volume71.0K
Market Cap8.63M
P/E Ratio19.80
EPS$0.96
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.14M | 1.91M | 1.66M |
| Net Income | 363.4K | 328.9K | 295.4K |
| Profit Margin | 17.0% | 17.2% | 17.7% |
| EBITDA | 556.5K | 495.2K | 517.1K |
| Free Cash Flow | 529.0K | 411.8K | 446.0K |
| Rev Growth | +7.4% | -9.8% | +4.5% |
| Debt/Equity | 0.19 | 0.19 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |